IL324224A - Anti-ngf vaccine composition - Google Patents

Anti-ngf vaccine composition

Info

Publication number
IL324224A
IL324224A IL324224A IL32422425A IL324224A IL 324224 A IL324224 A IL 324224A IL 324224 A IL324224 A IL 324224A IL 32422425 A IL32422425 A IL 32422425A IL 324224 A IL324224 A IL 324224A
Authority
IL
Israel
Prior art keywords
subunit
ngf
protein
sequence
polypeptide
Prior art date
Application number
IL324224A
Other languages
English (en)
Hebrew (he)
Inventor
ZAGURY Jean-Fran?ois
Do Herv?
Mascret A?Da
Salles Jean-Pierre
Azoulai Ren?
MOREAU Gabriel
LANGENFELD Florent
Desallais Lucille
Mouhsine Hadley
Original Assignee
Peptinov
Conservatoire Nat Des Arts Et Metiers Cnam
Jean Fran?Ois Zagury
Do Herv?
Mascret A?Da
Jean Pierre Salles
Azoulai Ren?
MOREAU Gabriel
LANGENFELD Florent
Desallais Lucille
Mouhsine Hadley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptinov, Conservatoire Nat Des Arts Et Metiers Cnam, Jean Fran?Ois Zagury, Do Herv?, Mascret A?Da, Jean Pierre Salles, Azoulai Ren?, MOREAU Gabriel, LANGENFELD Florent, Desallais Lucille, Mouhsine Hadley filed Critical Peptinov
Publication of IL324224A publication Critical patent/IL324224A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
IL324224A 2023-04-24 2025-10-26 Anti-ngf vaccine composition IL324224A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2304118A FR3148027A1 (fr) 2023-04-24 2023-04-24 Composition vaccinale anti-ngf
PCT/EP2024/061328 WO2024223713A1 (fr) 2023-04-24 2024-04-24 Composition vaccinale anti-ngf

Publications (1)

Publication Number Publication Date
IL324224A true IL324224A (en) 2025-12-01

Family

ID=89574029

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324224A IL324224A (en) 2023-04-24 2025-10-26 Anti-ngf vaccine composition

Country Status (7)

Country Link
EP (1) EP4701646A1 (de)
KR (1) KR20260040522A (de)
CN (1) CN121666242A (de)
AU (1) AU2024261873A1 (de)
FR (1) FR3148027A1 (de)
IL (1) IL324224A (de)
WO (1) WO2024223713A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60123399T2 (de) * 2000-01-18 2007-08-23 The Texas A & M University System, College Station Pharmazeutische zubereitungen enthaltend beta-turn peptidomimetische zyklische substanzen
KR100894191B1 (ko) * 2003-07-15 2009-04-22 암젠 인코포레이티드 선택적인 ｎｇｆ 경로 저해제로서의 인체 항-ｎｇｆ 중화 항체 및 이 항체를 포함하는 약학적 조성물
AU2016247195A1 (en) * 2003-07-15 2016-11-10 Amgen Inc. Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors
CN102408483B (zh) * 2003-07-15 2016-06-08 安姆根有限公司 作为选择性ngf途径抑制剂的人抗ngf中和抗体
US20080019991A1 (en) 2004-06-02 2008-01-24 Cytos Biotechnology Ag Carrier Conjugates Of Tnf-Peptides
ME00226B (me) * 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
GB201114858D0 (en) * 2011-08-29 2011-10-12 Nvip Pty Ltd Anti-nerve growth factor antibodies and methods of using the same

Also Published As

Publication number Publication date
AU2024261873A9 (en) 2025-12-04
EP4701646A1 (de) 2026-03-04
KR20260040522A (ko) 2026-03-24
AU2024261873A1 (en) 2025-11-27
WO2024223713A1 (fr) 2024-10-31
CN121666242A (zh) 2026-03-13
FR3148027A1 (fr) 2024-10-25

Similar Documents

Publication Publication Date Title
JP5901714B2 (ja) アルファシヌクレイン・エピトープのミモトープのレヴィ小体病治療への使用
EA014112B1 (ru) Моноклональное антитело к миостатину и способы его применения
JPH09505031A (ja) 外来ｔ−細胞エピトープを補助として用いた、自己タンパク質に対する抗体応答の誘発
US20170333539A1 (en) Anti-il-6 vaccine composition
JP7560365B2 (ja) 抗ｐｄ－ｌ１ワクチン組成物
CN116041544A (zh) 二价新冠疫苗及其制备方法及用途
JP2026027267A (ja) 術後痛を予防又は治療するための医薬組成物
IL324224A (en) Anti-ngf vaccine composition
US20250042962A1 (en) Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use
JP2021516992A (ja) 抗ｐｄ−１ワクチン組成物
US20240299567A1 (en) Recombinant polypeptides, conjugates comprising the same, and uses thereof
CN115594770A (zh) 一种针对人TNFα分子的类风湿关节炎治疗性疫苗的构建
JPH03503237A (ja) 細胞性応答を誘発するトリコクシジウム症抗原をコードするクローン化遺伝子、およびその製造方法
KR102779372B1 (ko) p40-EBI3의 복합체 및 이의 용도
CN103539840B (zh) 表皮生长因子受体模拟表位肽及其应用
CN102127147B (zh) 表皮生长因子受体模拟表位肽及其应用
US9301997B2 (en) Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptides
WO2025017537A1 (en) Active immunization for treating atopic dermatitis
CN101049502B (zh) 用于治疗变应性嗜酸细胞性疾病的展示il-5、il-13或嗜酸细胞活化趋化因子的抗原阵列
JP2026041716A (ja) インターロイキン－６に対して指向される免疫応答を誘導するための免疫原性複合体
WO2023190496A1 (ja) 抗ネトリン－４抗体およびその利用
JP2022131943A (ja) ワクチン、医薬及び糖尿病合併症治療薬